MindImmune
About
What does MindImmune do?
MindImmune is a startup focused on leveraging artificial intelligence to develop novel diagnostic tools for neurodegenerative diseases. Their approach aims to enable earlier and more accurate detection, potentially leading to improved patient outcomes and treatment strategies. The company emphasizes the use of advanced AI and machine learning techniques to analyze complex biological data.
What is MindImmune's revenue?
StartupHub estimates MindImmune's annual revenue at $65.9M (range $36.1M to $170.5M, 44% confidence), based on comparable companies in the sector.
What is MindImmune's valuation?
StartupHub estimates MindImmune's effective valuation at $1.1B (range $775.4M to $1.4B, 41% confidence), based on comparable companies in the sector.
How much funding has MindImmune raised?
MindImmune has raised a total of $35M in funding. The most recent round on record is Strategic Investment.
Where is MindImmune headquartered?
MindImmune is headquartered in Paris, France.
When was MindImmune founded?
MindImmune was founded in 2021.
What industry does MindImmune operate in?
MindImmune operates in Biotechnology, Artificial Intelligence, Healthcare, Diagnostics.
No comments yet. Be the first to share your take.